Innovation beyond distribution
Distribution is our backbone — but our group also invests in retail, human pharma, R&D and digital veterinary innovation.
Petfirst — veterinary pharmacy network
Our flagship Petfirst veterinary pharmacy opened in Budapest in 2020, followed by a second Budapest location and a third in Tata in 2021. The Petfirst webshop launched the same year, offering a comprehensive range of premium products for pets and their owners — all under professional veterinary supervision.
Human pharmaceutical line
Since 2017 we have operated in the human pharmaceutical sector as the exclusive distributor of HyaloBarrier and HyaloBarrier Endo — premium anti-adhesion gels designed to prevent or reduce post-surgical adhesions in the abdomino-pelvic area. In 2018 we extended this partnership to Contipro human wound-healing products, based on the highest quality hyaluronic acid.
R&D — osteoarthritis biomarkers
In collaboration with a Dipl. ECVCP and several Hungarian Key Opinion Leaders, we submitted a Research & Development tender to identify and validate biomarkers for the enhanced diagnosis and clinical assessment of osteoarthritis.
Pet owner — expert connection app
We initiated the development of an app designed to connect responsible pet owners with medical experts, ensuring a positive experience and support for owners — even when facing challenging medical conditions.
Nova Vet Family — AI for veterinary clinics
Launched in 2026, the Nova Vet Family is an innovative digital platform for veterinary clinics powered by Artificial Intelligence — a state-of-the-art solution designed to revolutionise clinic management and digital diagnostics.